FOXO1 and central nervous system cancer: Likewise, in a recent study with a small sample size by Huang et al. immune-cytoplasmic-staining scores of FOXO1a helped distinguish low-grade-gliomas from non-neoplastic lesions but did not correlate significantly with WHO grades [131].